T Feldman
Overview
Explore the profile of T Feldman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
119
Citations
843
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kaplan T, Feldman T, Healey B, Behn M, Glanz B, Chitnis T
Mult Scler Relat Disord
. 2023 Apr;
74:104672.
PMID: 37031553
Background: Low sexual function and satisfaction are common problems among people with multiple sclerosis (PwMS), but the literature on which patient variables are associated with these issues is inconsistent. Objective:...
2.
Horwitz S, OConnor O, Pro B, Trumper L, Iyer S, Advani R, et al.
Ann Oncol
. 2021 Dec;
33(3):288-298.
PMID: 34921960
Background: For patients with peripheral T-cell lymphoma (PTCL), outcomes using frontline treatment with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP-like therapy are typically poor. The ECHELON-2 study demonstrated that...
3.
Shlush L, Feldman T
J Intern Med
. 2021 Jan;
289(5):636-649.
PMID: 33511694
Haematopoietic stem and progenitor cells (HSPCs) are defined as unspecialized cells that give rise to more differentiated cells. In a similar way, leukaemic stem and progenitor cells (LSPCs) are defined...
4.
Abramson J, Feldman T, Kroll-Desrosiers A, Muffly L, Winer E, Flowers C, et al.
Ann Oncol
. 2014 Sep;
25(11):2211-2217.
PMID: 25193992
Background: Optimal frontline therapy for peripheral T-cell lymphoma (PTCL) in the modern era remains unclear. Patients And Methods: We examined patient characteristics, treatment, and outcomes among 341 newly diagnosed PTCL...
5.
Straus D, Duvic M, Horwitz S, Hymes K, Goy A, Hernandez-Ilizaliturri F, et al.
Ann Oncol
. 2013 Nov;
25(1):206-10.
PMID: 24285015
Background: High response rates for doxorubicin HCl liposome injection (DLI) in cutaneous T-cell lymphoma (CTCL) have been reported with vague criteria until recently. Approximately 50% of CTCL patients respond to...
6.
Zhang Z, Mahoney E, Gershony G, Ellis S, Saucedo J, Talley J, et al.
Am Heart J
. 2001 Nov;
142(6):982-8.
PMID: 11717601
Background: The Simple and Effective Arterial Closure (SEAL) trial examined the safety and effectiveness of the Duett vascular sealing device (Vascular Solutions, Minneapolis, Minn) versus manual compression after diagnostic and...
7.
Fearon W, Luna J, Samady H, Powers E, Feldman T, Dib N, et al.
Circulation
. 2001 Oct;
104(16):1917-22.
PMID: 11602494
Background: Determination of fractional flow reserve (FFR) has been proposed as a means to assess stent deployment. In this prospective, multicenter trial, we evaluate the use of FFR to optimize...
8.
Ledesma M, Alva C, Gomez F, Diaz y Diaz E, ARGUERO R, Feldman T
Am J Cardiol
. 2001 Sep;
88(4):460-2.
PMID: 11545780
No abstract available.
9.
Fusman B, Faxon D, Feldman T
Catheter Cardiovasc Interv
. 2001 Aug;
53(4):553-61.
PMID: 11515013
No abstract available.
10.